Basic Information
| LncRNA/CircRNA Name | LINC01602 |
| Synonyms | NA |
| Region | GRCh38_8:57978358-57984126 |
| Ensemble | ENSG00000205293 |
| Refseq | NR_130934 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | qRT-PCR |
| Sample | TCGA |
| Expression Pattern | up-regulated |
| Function Description | Multivariable Cox regression analysis was used to establish a prognostic risk formula including three lncRNAs (AP003555.2, AP006284.1, and LINC01602).The low-risk group had a better OS than the high-risk group (P < 0.0001), and the areas under the receiver operating characteristic curve (AUCs) of 3- and 5-year OS were 0.712 and 0.674, respectively. |
| Pubmed ID | 31824849 |
| Year | 2019 |
| Title | An Integrated Three-Long Non-coding RNA Signature Predicts Prognosis in Colorectal Cancer Patients |
External Links
| Links for LINC01602 | GenBank HGNC NONCODE |
| Links for colorectal cancer | OMIM COSMIC |